Takeda Pharmaceutical Co Ltd (TKPHF) — SC 13D/A Filings
All SC 13D/A filings from Takeda Pharmaceutical Co Ltd. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Takeda Pharma Files 13D/A Amendment on Phathom
— Apr 10, 2024 Risk: medium
Takeda Pharmaceutical Co Ltd, through its subsidiary 03 Life Sciences, has filed an amendment (Amendment No. 7) to its Schedule 13D concerning Phathom Pharmaceu -
Takeda Pharma Files 13D/A Amendment on Phathom Holdings
— Apr 1, 2024 Risk: medium
Takeda Pharmaceutical Co Ltd filed an amendment (No. 6) to its Schedule 13D on April 1, 2024, concerning its holdings in Phathom Pharmaceuticals, Inc. The filin -
Takeda Cuts Phathom Stake to 14.9%, Now Holds 10M Shares
— Jan 25, 2024
Takeda Pharmaceutical Company Limited filed an amendment (SC 13D/A) on January 25, 2024, updating its ownership in Phathom Pharmaceuticals, Inc. Takeda now bene
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX